Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1

• DOI: 10.1016/j.jtho.2025.03.033
• Publication Date: 2025-03-19T08:12:23Z
• Authors: Saadettin Kilickap; Ana Baramidze; Ahmet Sezer; Mustafa Özgüroğlu; Mahmut Gumus; Igor Bondarenko; Miranda Gogishvili; Marina Nechaeva; Michael Schenker; Irfan Cicin; Ho Gwo Fuang; Yaroslav Kulyaba; Kasimova Zyuhal; Roxana-Ioana Sche...; Marina Chiara Gar...; Yuntong Li; Cong Zhu; Manika Kaul; Javier Perez; Frank Seebach; Israel Lowy; Jean-Francois Pou...; Eric Kim; Heather Magnan
• Keywords: Expression (computer science); Line (geometry)